Prospective Observational Study on Ustekinumab (Stelara) Assessing Efficacy and Healthcare Resource Utilization in Crohn's Disease
Clinical trial NCT03495973 · COMPLETED
Trial details
- NCT number
- NCT03495973
- Sponsor
- Janssen-Cilag Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-10-25
- Primary completion
- 2020-11-22
- Enrollment
- 114
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.